Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02131376 · ClinicalTrials.gov registry record · NA
Investigating a Novel Modifiable Factor Affecting Renal Function After Partial Nephrectomy: Cortical Renorrhaphy
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02131376 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 26 participants.
The verdict
NCT02131376, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Preserving kidney function during removal of a kidney tumor is becoming increasingly important as rates of chronic kidney disease increase. A novel modifiable factor (suture closure of the defect caused by tumor removal) was discovered on retrospective studies to account for nearly two-thirds of the 15% volume loss commonly seen in operated kidneys. We hypothesize that a randomized controlled surgical trial will show that omitting the suture closure both preserves renal function and will not lead to unreasonable postoperative complications.
Interventions
- PROCEDURE Non-renorrhaphy
- PROCEDURE Renorrhaphy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-05-09 |
| Est. Completion | 2019-08-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02131376
The ClinicalTrials.gov registry entry for NCT02131376 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Non-renorrhaphy is the first listed.
NCT02131376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02131376 about?
NCT02131376 is a clinical study titled "Investigating a Novel Modifiable Factor Affecting Renal Function After Partial Nephrectomy: Cortical Renorrhaphy". Preserving kidney function during removal of a kidney tumor is becoming increasingly important as rates of chronic kidney disease increase. A novel modifiable factor (suture closure of the defect caused by tumor removal) was discovered on retrospective studies to account for nearly two-thirds of the...
What is the current status of trial NCT02131376?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2014-05-09. Estimated completion is 2019-08-29.
What interventions are being tested in trial NCT02131376?
The interventions under investigation include: Non-renorrhaphy (PROCEDURE), Renorrhaphy (PROCEDURE).
Who is sponsoring clinical trial NCT02131376?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.